Trial intelligence / Profile preview

Bioequivalence of Crushed Triumeq vs Whole Tablet

NCT02569346Phase 1Completed

Sponsor
Radboud University Medical Center
Start
Mar 2016
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of abacavir in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Radboud University Medical Center. Primary endpoint: Area Under the Curve up to 48 hours. Started Mar 2016; status: completed.

02

Drugs

abacavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT02569346.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02569346.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call